Latest Posts

Results of CARsgen’s Satri-cel for Adjuvant Treatment for Gastric Cancer Presented at ESMO Congress 2026

Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity

26th Shanghai Fair Returns to Kuala Lumpur to Strengthen Trade and Cultural Ties

RIMAN Connects Global Direct Selling Leaders with K-Beauty Innovation Through WFDSA World Congress and Jeju Experience Tour

SHARE

← All PR Newswire releases

Source: PR Newswire · RIMAN · View original release

  • RIMAN participated as a Platinum Sponsor of the 18th WFDSA World Congress, highlighting its proprietary ingredients and R&D capabilities
  • The company hosted 24 direct selling industry representatives from nine countries for an exclusive brand experience on Jeju Island

SEOUL, South Korea, Oct. 26, 2026 /PRNewswire/ — RIMAN, a global K-beauty and wellness company, reinforced its presence in the international direct selling industry through its Platinum Sponsorship of the 18th World Federation of Direct Selling Associations (WFDSA) World Congress and an exclusive brand experience on Jeju Island.

RIMAN Founder and Chairman Joong Hyun Ahn delivers a presentation during the 2026 WFDSA World Congress in Incheon, South Korea.
RIMAN Founder and Chairman Joong Hyun Ahn delivers a presentation during the 2026 WFDSA World Congress in Incheon, South Korea.

Held October 19–21 at INSPIRE Entertainment Resort in Incheon, South Korea, the triennial congress brought together direct selling industry leaders from around the world. As a Platinum Sponsor, RIMAN showcased its flagship brands, including ICD, botalab, and Lifening, alongside its proprietary ingredient, Giant BYoungPool™. RIMAN Founder and Chairman Joong Hyun Ahn spoke at the “Korea Market Spotlight: Innovation Builds. People Transform.” session, sharing RIMAN’s growth story built on proprietary ingredients, R&D capabilities, and people-centered leadership.

Building on the congress, RIMAN hosted the “RIMAN JEJU EXPERIENCE,” an exclusive brand immersion program designed to offer international direct selling industry leaders firsthand insights into the company’s proprietary ingredients, R&D capabilities, and brand philosophy. Held from October 22–24 on Jeju Island, the program welcomed 24 industry representatives from nine countries, including France, Germany, China, and Singapore.

Participants explored RIMAN’s value chain, from ingredient cultivation to research and product development. At RIMAN FARM, a smart farm cultivating Giant BYoungPool™, a proprietary variety of Centella asiatica, they learned about its cultivation and RIMAN’s ingredient research. They also stayed at RIMAN VILLAGE, a branded resort built by RIMAN exclusively for its distributors, experiencing Lava BYoungPool spa treatments and RIMAN’s beauty and wellness products.

“Witnessing the advanced technology and ingredient research firsthand strengthened my confidence in RIMAN’s products,” one participant said.

Frédéric Billon, Executive Director of the French Direct Selling Association (FVD), also praised RIMAN’s approach, saying, “Managing everything from raw ingredients to finished products is a smart strategy that positions RIMAN to lead the future beauty market, driven by sustainability.”

“The WFDSA World Congress and RIMAN JEJU EXPERIENCE showcased our proprietary ingredients and R&D capabilities,” said Youngsu Hwang, Chief Sales Officer of RIMAN. “We were especially pleased by participants’ positive responses to our product development process and employees’ dedication. We will continue strengthening our global connections and position as a trusted K-beauty brand.”

About RIMAN

Founded in 2018 in South Korea, RIMAN is a global beauty and wellness direct-selling company redefining K-Beauty through heritage ingredients from Jeju Island and cutting-edge innovation. At its Jeju Smart Farm, RIMAN manages every step, from raw material cultivation to product development, including its signature ingredient, Giant BYoungPool™—an advanced Centella Asiatica cultivar granted 20-year Plant Variety Protection by the Korea Forest Service in July 2022 and the U.S. Department of Agriculture (USDA) in September 2025.

Posted in

RELATED ARTICLES

Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity

Source: PR Newswire · Ascletis Pharma Inc. · View original release - ASC39, an oral small molecule selective amylin receptor agonist, demonstrated eloralintide-like amylin selectivity...

2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein

Source: PR Newswire · Innovent Biologics · View original release The data showcased are from three Phase 1b clinical studies of IBI363/TAK-928 in first-line NSCLC,...

uSMART and PIVOT Fintech Introduce GlobalSave Portfolios Balanced Strategy on FollowSmart

Source: PR Newswire · uSMART Securities (Singapore) Pte Ltd · View original releaseSINGAPORE, Oct. 26, 2026 /PRNewswire/ -- uSMART Securities (Singapore) Pte. Ltd. ("uSMART") has...

From Vietnam National Brand to Regional Giant: SUNHOUSE Secures Second Consecutive APEA Corporate Excellence Award

Source: PR Newswire · SUNHOUSE Group · View original releaseHANOI, Vietnam, Oct. 26, 2026 /PRNewswire/ -- At the Asia Pacific Enterprise Awards (APEA) 2026, SUNHOUSE...

Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026

Source: PR Newswire · Antengene Corporation Limited · View original release SHANGHAI and HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK:...

26th Shanghai Fair Returns to Kuala Lumpur to Strengthen Trade and Cultural Ties

Source: PR Newswire · RCG International Convention & Exhibition Co. Limited · View original releaseKUALA LUMPUR, Malaysia, Oct. 26, 2026 /PRNewswire/ -- The 26th Shanghai...

Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity

Source: PR Newswire · Ascletis Pharma Inc. · View original release - ASC39, an oral small molecule selective amylin receptor agonist, demonstrated eloralintide-like amylin selectivity...

2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein

Source: PR Newswire · Innovent Biologics · View original release The data showcased are from three Phase 1b clinical studies of IBI363/TAK-928 in first-line NSCLC,...

uSMART and PIVOT Fintech Introduce GlobalSave Portfolios Balanced Strategy on FollowSmart

Source: PR Newswire · uSMART Securities (Singapore) Pte Ltd · View original releaseSINGAPORE, Oct. 26, 2026 /PRNewswire/ -- uSMART Securities (Singapore) Pte. Ltd. ("uSMART") has...

Don't Miss

image

World Cup Fans Hear About the Greatest Victory Through Jesus

Screen Shot 2026-07-09 at 11.47.07 AM

GAME ON: SPORTS ANIME TO WATCH DURING THE FIFA WORLD CUP ON CRUNCHYROLL

image

Christian Athletes Bring Their Faith to the World Cup Stage

image

Standing Amid the Storm: Indiana Crucifix Inspires Hope